The start up Celtarys Research, born at the University of Santiago de Compostela and dedicated to the development of fluorescent tools for drug discovery, has closed a seed capital investment round of 650,000 euros. In the round have participated the Galician institutional funds of the Xunta de Galicia – through XesGalicia – and VigoActivo, as […]
DUBAI – NanoCellect Biomedical Inc. a privately-held life sciences company, focused on developing microfluidic based cell analysis and sorting solutions, has signed an agreement appointing Alliance Global (AGBL Group) as the exclusive distributor in the Middle East, Africa, Levant, Turkey, Pakistan, Bangladesh and Sri Lanka. Dr. Will Alaynick, Co-founder and Vice President International at NanoCellect […]
AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays. Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a […]
CAMBRIDGE, MA—Draper has received a $719,000 federal contract from the U.S. Department of Health and Human Services (HHS) to enhance the company’s tissue-chip platform for advanced studies of viral infection. With the contract, Draper will design a model for human airway tissue and adapt its PREDICT96 platform to collect data for SARS-CoV-2 infection studies. The […]
The Oxford Nanopore “Q20+” kit is now available to any Oxford Nanopore user who registers their interest. As part of this Early Access programme, Oxford Nanopore will make available its latest flow cell chemistry, “R10.4” for first user trials. First announced at the London Calling conference in May 2021, the Q20+ chemistry enables users to generate […]
AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays. Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with deepCDR, a private company focused on applying deep learning algorithms to antibody discovery and optimization. “We continue to leverage and integrate cutting-edge technologies […]
PROVEN BISULFITE TECHNOLOGY IDEAL FOR CLINICAL APPLICATIONS Zymo Research’s EZ DNA Methylation-Lightning Kit has been granted the CE IVD Mark which allows the technology to be distributed within the European Union (EU) common market. IRVINE, Calif. — Today Zymo Research announced its EZ DNA Methylation-Lightning Kit has received the CE IVD Mark allowing the technology to be distributed […]
Unique approach harnesses Evonetix’s thermally-controlled DNA-on-chip technology to simplify writing, accessing and reading stored DNA Demonstrates potential application of Evonetix’s technology beyond gene synthesis Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has been granted patent GB 2576304 for its […]
BRANFORD, Conn. — IsoPlexis, a leader in functional single-cell proteomics, today announced the appointment of Dr. Jason Myers to its Board of Directors. Dr. Myers joins IsoPlexis’ Board of Directors with a wealth of experience in genomics, product development, and business leadership. Dr. Myers is the Chief Executive Officer at GenapSys, and a former board member of Invitae […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
